Introduction: There is scarce evidence demonstrating a relationship between glycemic control or glycemic variability with diabetic retinopathy (DR).

Objectives: We aimed to determine the prevalence of DR and its association with time in range (TIR), and other association factors.

Methods: We performed a retrospective observational study with 130 T1DM patients on continuous subcutaneous insulin infusion (CSII). Data of the three previous months were downloaded and analyzed.

Results: Mean age was 37±13 years-old. 51.5% were female. Mean BMI was 24.8±4.0 Kg/m2. Duration of T1DM was 21±10 years. The mean HbA1c was 7.1±0.8%; before CSII 7.4±1.0%. Mean LDL-c was 100±26 mg/dL. The prevalence of DR was 20.8% (95%CI: 14.7 - 28.5); 19.2% non-proliferative DR and 1.5% proliferative DR. Most glycemic control and variability parameters were significantly higher in the DR+ group (Table 1). After applying the stepwise logistic regression model (p<0.001, R2 0.561), the association factors for developing DR were: LDL-c, ExpB 0.97 (95%CI 0.95-0.99); duration of DM, ExpB 1.26 (95%CI 1.12-1.41); and HbA1c before CSII, ExpB 2.24 (95%CI 1.17-4.31).

Conclusions: Lower TIR and higher time in hyperglycemia were observed in patients with DR. LDL-c levels, long duration of DM and higher HbA1c before CSII were independent association factors for the development of DR.

graphic
View largeDownload slide
Disclosure

E. Lecumberri: None. N. Bengoa: None. M. Fernández Argüeso: None. L. Nattero Chávez: None.

© 2020 by the American Diabetes Association
2020
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.